Avigen

Avigen is a biotechnology Contract Research Organisation supporting preclinical immunotherapy and cell therapy research and development. The company uses a proprietary microfluidic platform to measure cellular avidity, helping biotech, pharma and research teams identify, rank, sort and validate immune-cell candidates with stronger therapeutic potential. Its services focus on immunotherapy discovery and validation, particularly for TCR-T, CAR-T, NK and related cellular therapies targeting solid tumours. By analysing live immune–target cell interactions at high throughput while preserving cell viability, Avigen provides translational insights that help customers de-risk development, optimise candidate selection and advance more confident preclinical programmes.